High Antiplasmodial Activity of Novel Plasmepsins I and II Inhibitors-Reference-Cited by-同舟云学术

High Antiplasmodial Activity of Novel Plasmepsins I and II Inhibitors

Published:2006-11-16 Issue:25 Volume:49 Page:7440-7449
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Dell'Agli Mario¹,Parapini Silvia¹,Galli Germana¹,Vaiana Nadia¹,Taramelli Donatella¹,Sparatore Anna¹,Liu Peng¹,Dunn Ben M.¹,Bosisio Enrica¹,Romeo Sergio¹

Affiliation:

1. Department of Pharmacological Sciences, Department of Public Health-Microbiology-Virology, and Institute of Medicinal Chemistry, School of Pharmacy, University of Milan, Milan 20100, Italy, and Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida 32610

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm061033d

Reference30 articles.

1. Mediation of pathogen resistance by exudation of antimicrobials from roots

2. Antimalarial drug resistance

3. Drug Resistance Hampers Our Capacity to Roll Back Malaria

4. Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine

5. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral acute toxicity study and in vivo antimalarial activity of Strychnos lucida R. Br. tablet;Journal of Ethnopharmacology;2024-08

2. From DC18 to MR07: A Metabolically Stable 4,4′‐Oxybisbenzoyl Amide as a Low‐Nanomolar Growth Inhibitor of P. falciparum;ChemMedChem;2022-09-26

3. Plasmepsins as targets for antimalarial agents;Antimalarial Agents;2020

4. Discovery and Pharmacophore Mapping of a Low‐Nanomolar Inhibitor of P. falciparum Growth;ChemMedChem;2019-11-12

5. Road Towards Development of New Antimalarial: Organelle Associated Metabolic Pathways in Plasmodium as Drug Targets and Discovery of Lead Drug Candidates;Pathogenicity and Drug Resistance of Human Pathogens;2019